Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
The following section summarizes insights on Abbott Laboratories's Net Income to Stockholders Margin:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Income to Stockholders Margin in the popular category include:
A ratio that measures the amount of profit that stockholders earn on each dollar of revenue earned by the firm.
The chart above depicts the distribution of Net Income to Stockholders Margin for companies operating in the Healthcare Sector in the Developed economic region. Over 2,000 companies were considered in this analysis, and 1,926 had meaningful values. The average Net Income to Stockholders Margin of companies in the Sector is -1,115.1% with a standard deviation of 4,147.7%. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Abbott Laboratories's Net Income to Stockholders Margin of 31.9% ranks in the 95.5% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,006 |
| Included Constituents | 1,926 |
| Min | -45,635.8% |
| Max | 115.8% |
| Median | -24.0% |
| Mean | -1,115.1% |
| Standard Deviation | 4,147.7% |
You can find companies with similar Net Income to Stockholders Margin using this stock screener.